Specifically, CGB5 disrupts canonical TGF-β signaling, thereby driving fibroblasts to acquire a CAF phenotype characterized by robust secretion of ECM proteins and pro-inflammatory cytokines (42), ultimately remodeling the ECM and facilitating tumor invasion (41, 43). Here, CGB5 is linked to neoplasm.